Related Experiment Videos
Night-time nasal ventilation in neuromuscular disease
J Z Heckmatt1, L Loh, V Dubowitz
1Department of Paediatrics, Hammersmith Hospital, London.
Lancet (London, England)
|March 10, 1990
Summary
Nasal intermittent positive-pressure ventilation effectively treated sleep hypoventilation in 14 pediatric and adult patients with neuromuscular disorders. While well-tolerated by most, younger patients experienced difficulties with nasal mask use.
Area of Science:
- Pediatric Pulmonology
- Neuromuscular Disorders
- Sleep Medicine
Background:
- Symptomatic sleep hypoventilation is a common complication in patients with neuromuscular disorders.
- Traditional ventilation methods like cuirass or iron lungs can be cumbersome and invasive.
Purpose of the Study:
- To evaluate the efficacy and tolerance of nasal intermittent positive-pressure ventilation (NIPPV) in patients with neuromuscular disorders and sleep hypoventilation.
Main Methods:
- A cohort of 14 patients (aged 2-28 years) with neuromuscular disorders and symptomatic sleep hypoventilation were treated with nocturnal NIPPV via a nasal mask.
- Nine patients were new to ventilation, while five had prior experience with cuirass or iron lung ventilation.
Main Results:
- NIPPV was highly effective in 10 out of 14 patients, significantly improving sleep hypoventilation.
- However, NIPPV was not tolerated by 4 of the 5 youngest patients, suggesting an age-related tolerance issue.
- NIPPV was preferred over other methods due to its non-invasive nature, quiet operation, portability, ease of use, and promotion of patient independence.
Conclusions:
- Nasal intermittent positive-pressure ventilation is a viable and effective treatment for sleep hypoventilation in many patients with neuromuscular disorders.
- Careful consideration of patient age and tolerance is necessary, particularly for the youngest individuals.
- NIPPV offers significant advantages in terms of patient comfort and independence compared to traditional ventilation systems.